-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S9Xyc3qMj7mz4fvBkxiBuz0fS5GRttFPLQbv83jAcFrxfunMa9GmOn+9HroI48hr /9HwGsYgiSOudNtuNJ7qyg== 0001104659-06-022277.txt : 20060404 0001104659-06-022277.hdr.sgml : 20060404 20060404213617 ACCESSION NUMBER: 0001104659-06-022277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060401 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABGENIX INC CENTRAL INDEX KEY: 0001052837 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943248826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5106086500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEHRENS M KATHLEEN CENTRAL INDEX KEY: 0001211701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24207 FILM NUMBER: 06740364 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 a4.xml 4 X0202 4 2006-04-01 1 0001052837 ABGENIX INC ABGX 0001211701 BEHRENS M KATHLEEN 6701 KAISER DRIVE FREMONT CA 94555 1 0 0 0 Common Stock, par value $0.0001 per share 2006-04-01 4 D 0 100115 22.50 D 0 D Common Stock, par value $0.0001 per share 2006-04-01 4 D 0 31800 22.50 D 0 I By Trust Common Stock, par value $0.0001 per share 2006-04-01 4 D 0 7151 22.50 D 0 I Dy Daughter Common Stock, par value $0.0001 per share 2006-04-01 4 D 0 7151 22.50 D 0 I By Son Non- Qualified Stock Option (right to buy) 1.50 2006-04-01 4 D 0 120000 D 1998-02-18 2008-02-18 Common Stock, par value $0.0001 per share 120000 0 D Non- Qualified Stock Option (right to buy) 3.5937 2006-04-01 4 D 0 30000 D 1999-06-02 2009-06-02 Common Stock, par value $0.0001 per share 30000 0 D Non- Qualified Stock Option (right to buy) 12.49 2006-04-01 4 D 0 10000 D 2002-06-04 2012-06-04 Common Stock, par value $0.0001 per share 10000 0 D Non- Qualified Stock Option (right to buy) 10.99 2006-04-01 4 D 0 15000 D 2003-06-27 2010-06-27 Common Stock, par value $0.0001 per share 15000 0 D Non- Qualified Stock Option (right to buy) 13.36 2006-04-01 4 D 0 15000 D 2004-06-07 2011-06-07 Common Stock, par value $0.0001 per share 15000 0 D Non- Qualified Stock Option (right to buy) 7.70 2006-04-01 4 D 0 20000 D 2005-06-13 2012-06-13 Common Stock, par value $0.0001 per share 20000 0 D The shares are owned by an administrative trust, of which Dr. Behrens is a trustee and beneficiary. This option was converted into an option to acquire 37,200 shares of Amgen Inc. common stock at an exercise price of $4.84 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 9,300 shares of Amgen Inc. common stock at an exercise price of $11.60 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 3,100 shares of Amgen Inc. common stock at an exercise price of $40.29 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 4,650 shares of Amgen Inc. common stock at an exercise price of $35.46 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 4,650 shares of Amgen Inc. common stock at an exercise price of $43.10 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 6,200 shares of Amgen Inc. common stock at an exercise price of $24.84 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. /s/ George F. Fraley (Attorney-in-Fact) 2006-04-01 -----END PRIVACY-ENHANCED MESSAGE-----